Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,771 total articles
Tvardi Therapeutics announced its first quarter 2026 financial results and provided updates on its clinical programs targeting STAT3-driven diseases. The company expects topline data for its next-generation STAT3 inhibitor TTI-109 from a healthy volunteer study in June 2026 and Phase 1b/2 trial results for TTI-101 in hepatocellular carcinoma in the…
MapLight Therapeutics, a clinical-stage biopharmaceutical company specializing in central nervous system disorders, announced its management team's participation in the 2026 RBCCM Global Healthcare Conference and the 2026 Jefferies Global Healthcare Conference. The company focuses on developing circuit-specific pharmacotherapies using a novel disco…
TeraWulf Inc. reported its Q1 2026 financial results showing $34.0 million total revenue including $21.0 million from high-performance computing (HPC) lease revenue, highlighting its transition towards stable, contracted revenue. The company energized 60 MW of HPC capacity at its Lake Mariner facility, progressing on key construction projects, and …
Boundless Bio reported first quarter 2026 financial results highlighting continued enrollment in its KOMODO-1 first-in-human clinical trial of BBI-940, an oral selective kinesin degrader targeting oncogene amplified cancers. The company presented promising preclinical data at AACR 2026 demonstrating robust anti-tumor activity and tumor regressions …
Hyperion DeFi, the first U.S. publicly listed DeFi company building on the Hyperliquid blockchain, has completed a public offering of 2,777,778 shares of common stock at $3.60 per share, raising approximately $10 million before expenses. The proceeds will be used to fund the company’s HYPE token treasury strategy and for general corporate purposes.…
Regeneron Pharmaceuticals has been named to the Dow Jones Best-in-Class World Index for seven consecutive years and North America Index for six years. The recognition highlights the company's commitment to sustainability, corporate responsibility, and patient access, exemplified by offering its new gene therapy for a form of genetic hearing loss fo…
LENSAR, Inc. reported its financial results for Q1 2026, highlighting a 5% decline in total revenue to $13.4 million driven by reduced system sales amid acquisition-related market uncertainty. However, recurring revenue grew 9% to $12.6 million, comprising 94% of total revenue. The company installed 7 new ALLY Robotic Cataract Laser Systems, increa…
Applied Optoelectronics, Inc. announced equity grants of 299 restricted stock units to two new employees under its 2023 Equity Inducement Plan. These awards are intended as an incentive for joining the company and will vest over four years, subject to continuous employment. The plan complies with Nasdaq rules and is designed to attract talent to su…
Ultralife Corporation reported a decline in Q1 2026 revenue and profitability due to production disruptions and weaker sales in its communications systems segment, despite achieving a record backlog of $115 million. Operational challenges included power outages and inventory integration delays, impacting manufacturing efficiency and margins. The co…
AMC Global Media Inc. reported first quarter 2026 results highlighting 11% growth in streaming revenues to $174 million, driven by price increases despite a 1% decline in streaming subscribers. Total net revenues declined 2% to $542 million. The company generated $65 million in free cash flow but posted a GAAP net loss of $18.9 million, compared to…
First Advantage Corporation, a global software and data company specializing in identity solutions and risk management, announced that its management team will participate in several upcoming investor conferences including Needham Technology, William Blair Growth Stock, Stifel Boston Cross Sector, and Baird Global Consumer, Technology & Services. T…
Artiva Biotherapeutics announced the pricing of an underwritten offering of common stock and pre-funded warrants totaling approximately $300 million gross proceeds. The capital raise aims to support clinical development, including a planned Phase 3 trial of its lead AlloNK cell therapy targeting refractory rheumatoid arthritis and other autoimmune …
ANI Pharmaceuticals announced first quarter 2026 financial results with revenue growth of 20.5% year-over-year to $237.5 million and adjusted EBITDA increase of 24.1%. Notably, Cortrophin Gel revenue rose 42.1% to $75.1 million driven by expanded sales and demand momentum. The company raised its 2026 net revenue guidance to $1.08-$1.14 billion, adj…
Brookfield Asset Management Ltd. reported robust financial results for Q1 2026, including $21 billion raised in the quarter and $67 billion year-to-date. Fee-related earnings increased 11% to $772 million for the quarter and 18% annually to $3.1 billion. The company highlights growth in infrastructure, private equity, energy, real estate, and credi…
Brookfield Business Corporation announced its financial results for Q1 2026, highlighting a 5% organic increase in adjusted EBITDA despite a 50% decline in net income per Class A share compared to the prior year. The company benefited from a $1 billion annual cash tax credit related to its Clarios advanced energy storage operation, realized a 3x re…
Castellum, Inc., a cybersecurity and electronic warfare company focused on U.S. federal government contracts, announced Q1 2026 financial results showing a 23% revenue increase year-over-year to $14.3 million, improved gross profit, reduced net loss, and a debt-free balance sheet. The company also reported a record contract backlog of $273.3 millio…
Artiva Biotherapeutics announced positive initial clinical results from its AlloNK cell therapy for refractory rheumatoid arthritis (RA), showing a 71% ACR50 response rate at six months with a favorable outpatient tolerability profile. The FDA agreed on a design for a single Phase 3 registrational trial comparing AlloNK plus rituximab versus rituxi…
AirSculpt Technologies, Inc. reported flat revenue of $39.4 million and a slight increase in case volume in Q1 2026 compared to Q1 2025, with a reduced net loss of $2.4 million. The company reaffirmed its 2026 full-year revenue guidance of $151 - $157 million and adjusted EBITDA guidance of $15 - $17 million, highlighting a strengthened balance she…
Essent Group Ltd. reported net income of $171.8 million for Q1 2026, slightly down from $175.4 million in Q1 2025, with earnings per diluted share increasing to $1.82 from $1.69. The company declared a quarterly cash dividend of $0.35 per share. Mortgage new insurance written increased compared to the same quarter last year, while mortgage insuranc…
Artiva Biotherapeutics announced positive initial clinical data from its ongoing trials of AlloNK®, an allogeneic NK cell therapy combined with rituximab, showing a 71% ACR50 response rate in refractory rheumatoid arthritis patients with six months follow-up. The therapy demonstrated a favorable safety profile enabling outpatient administration in …
Strawberry Fields REIT, Inc., a real estate investment trust specializing in skilled nursing and healthcare-related properties, announced a cash dividend of $0.17 per common share for Q2 2026. The payment will be made on June 30, 2026, to shareholders of record as of June 16, 2026. The company owns 143 healthcare facilities across multiple U.S. sta…
KANZHUN LIMITED, a leading Chinese online recruitment platform known as BOSS Zhipin, announced it will release its unaudited consolidated results for Q1 2026 on May 20, 2026, before U.S. market open. The company will hold a conference call to discuss these results, providing investors an opportunity to gain insight into its latest operational and f…
Strawberry Fields REIT, Inc. announced solid Q1 2026 operating results with increased rental revenues, funds from operations (FFO), and net income compared to Q1 2025. The company signed a $300 million Corporate Credit Facility to refinance debt and support growth, and completed the acquisition of a hospital campus in Missouri, expanding its health…
Profusa, Inc., a digital health company specializing in tissue-integrated biosensors, announced that the Nasdaq Hearings Panel has granted their request to move their listing from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is contingent on meeting certain interim milestones, including bid price and stockholders' equity requ…
Super Hi International Holding Ltd., a leading operator of Haidilao hot pot restaurants internationally, announced it will release its unaudited financial results for the first quarter of fiscal year 2026 on May 20, 2026, before the U.S. market opens. Management will host a conference call and webcast to discuss the results.
